With respect to the sickle-cell allele, what should be true of the β hemoglobin locus in u. s. populations of african-americans whose ancestors were from equatorial africa? 1. the average heterozygosity at this locus should be decreasing over time. 2. there is an increasing heterozygote advantage at this locus. 3. diploidy is to preserve the sickle-cell allele at this locus. 4. frequency-dependent selection is to preserve the sickle-cell allele at this locus.

1. The average heterozygosity at this locus should be decreasing over time

3. Diploidy is helping to preserve the sickle-cell allele at this locus

Explanation:

Sickle cell anemia is caused by a mutation in the beta hemoglobin gene. The mutation substitutes amino acid valine for glutamic acid. The mutation makes the hemoglobin less soluble. The mutated hemoglobin forms crystal-like structures and affects the shape of RBCs. The RBCs carrying the mutated hemoglobin are sickle-shaped. The mutation is recessive in nature and the disease is expressed in homozygous recessive genotype. However, the heterozygous genotype exhibit resistance to malaria pathogen since the pathogen can not survive in altered RBCs. The presence of one normal allele prevents these heterozygous individuals to be affected by the disease.  

Therefore, the heterozygous genotype for sickle cell anemia is preferred by natural selection in malaria-prone regions such as Africa. The individuals with African ancestry would have higher heterozygosity at the beta hemoglobin locus. In American populations, homozygous recessive genotypes have a higher frequency as the disease is not expressed in recessive conditions and malaria is not prevalent there. So, the U.S. populations of African-Americans would exhibit reduced heterozygosity at the locus over generations.  

advantage of using stem cells in medical research:

1.       it provides medical benefits in the fields of therapeutic cloning and regenerative medicine.

2. it provides great potential for discovering treatments and cures to a variety of diseases including parkinson disease, spinal cord injuries, diabetes, alzheimer’s disease and many more.

3. limbs and organ could be grown in lab from stem cells and then used in transplant or treat illness.